Q4 2024 Earnings Call Transcript January 31, 2025 AbbVie Inc. misses on earnings expectations. Reported EPS is $2.16 EPS, expectations were $2.98. Operator: Good morning and thank you for standing by.

AbbVie's strong earnings and growth projections make it a solid buy for 2025, with no major patent expirations until 2030. Learn more on ABBV stock here.

Welcome to the AbbVie fourth-quarter 2024 Earnings Conference Call. [Operator instructions] Today's call is also being recorded. If you have any objections, you may disconnect at this time. I would ...

AbbVie's acquisition of Allergan significantly increased the firm's debt level. We expect the firm's net debt position to peak at close to $70 billion in 2020 but given the strong cash flows of AbbVie ...

Joey Luther was arrested last week and charged with wire fraud, smuggling and distributing counterfeit drugs for allegedly ...

Authorities in Victoria and New South Wales have issued public warnings about an unregistered cosmetic practitioner who ...

Forget turning back the clock. Gen Z is trying to stop it altogether. One of the latest wellness crazes: “Preventative Botox.” ...

Watch What Happens Live’ host is notorious for questioning his Real Housewives guests about their cosmetic procedures ...

The neurological condition can cause people like Robert F. Kennedy Jr. to have voices that break and can sound "strangled." ...

Do you want us to inject Botox into your masseter muscle?” the dentist asked. My brows furrowed, as this is a question I ...

Honestly still reeling from part one of The Real Housewives of New York reunion—specifically thanks to the second-hand awkwardness that radiated from my screen when Andy Cohen asked Jessel Taank what ...

CELEBRITIES have popularised a new wave of youthful trends that promote using regenerative injectables like Sculptra to get ...